Two COVID-19 cases were detected in employees of the tissue farm in Radviliškis district: the farm is monitored Business



[ad_1]

Jurgita Savickaitė, representative of the State Food and Veterinary Service, informed BNS on Sunday that the diseases had been detected in the tissue farm of the company “Šiaurės lapė” operating in Pavartyčiai.

According to data received by the Authority, workers infected by COVID-19 did not work directly with animals.

“No morbidity or mortality was observed among the tissues, the situation is known, the farm is being monitored,” said J. Savickaitė.

Virginija Rubanienė, director of Šiaurės lapė, told BNS on Sunday that an employee had been treated at Radviliškis Hospital for other ailments and had not been working since November 14. She was diagnosed with coronavirus on Friday after being tested before being sent to rehab.

Another employee was diagnosed with the infection on Thursday, but, according to V. Rubanienė, she had no closer contact with other employees or worked with live animals.

“We no longer have animals since Friday,” said V. Rubanienė.

She assured that 50 thousand. the tissues grown on the farm were put to sleep because “it is ripe and the time has come.” According to the director, in the past, animals raised for the fur industry were tested for infection in accordance with all requirements and no cases were identified.

This week, the first outbreak of Covid-19 was recorded on Thursday at a tissue farm in the Jonava district. The Agriculture Ministry said this week that it is confident that other tissue farms will not hide the outbreak if this occurs and will inform services urgently.

Coronavirus tissues grown in Lithuania were tested preventively when outbreaks of this virus were detected in tissue farms in Denmark, and later in Spain, Italy, the United States, the Netherlands, Sweden and Greece.

Danish authorities reported in early November that the coronavirus had mutated in tissues, carrying the risk that the altered virus could be fully or partially resistant to vaccines currently in development, rendering them ineffective or only partially effective.



[ad_2]